Skip to content

Clinical trials

Completed Overweight trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Status: Completed Country / region: Canada Clear all

97 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20041
20051
20071
20082
20093
20102
20112
20126
20138
20146
20155
20163
20175
201812
20197
20202
20215
20224
202310
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed97

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S12
Laval University8
University of Toronto6
Eli Lilly and Company5
University of British Columbia5
McMaster University4
University of Guelph4
Université de Sherbrooke4
AstraZeneca3
McGill University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight97
Obesity78
Weight Loss12
Insulin Resistance11
Diabetes Mellitus10
Metabolic Syndrome10
Diabetes Mellitus, Type 29
Cardiovascular Diseases6
Inflammation5
Body Weight4

Trials

Showing 1 to 25 of 97. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.